Page last updated: 2024-08-23

simvastatin and Nasopharyngeal Neoplasms

simvastatin has been researched along with Nasopharyngeal Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Sun, FR; Sun, LM; Wang, M; Wang, SL1
Bosq, J; Busson, P; Faigle, W; Hirashima, M; Keryer, C; Loew, D; Middeldorp, J; Nishi, N; Pioche-Durieu, C; Souquère, S1

Other Studies

2 other study(ies) available for simvastatin and Nasopharyngeal Neoplasms

ArticleYear
Simvastatin induces apoptosis of nasopharyngeal carcinoma cells through NF-κB signaling pathway.
    European review for medical and pharmacological sciences, 2020, Volume: 24, Issue:12

    Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mice; Mice, Nude; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; NF-kappa B; Signal Transduction; Simvastatin

2020
In nasopharyngeal carcinoma cells, Epstein-Barr virus LMP1 interacts with galectin 9 in membrane raft elements resistant to simvastatin.
    Journal of virology, 2005, Volume: 79, Issue:21

    Topics: Blotting, Western; Carcinoma; Cell Line; Cell Transformation, Viral; Cytotoxins; Drug Resistance; Galectins; Herpesvirus 4, Human; Humans; Immunoprecipitation; Intracellular Membranes; Mass Spectrometry; Microscopy, Electron; Nasopharyngeal Neoplasms; Protein Binding; Simvastatin; Tumor Cells, Cultured; Viral Matrix Proteins

2005